ANI Pharmaceuticals reported $15.17M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
AbbVie USD 5.72B 1.98B Jun/2025
ANI Pharmaceuticals USD 15.17M 11.02M Jun/2025
Aurora Cannabis CAD -20220000 56.44M Jun/2025
Canopy Growth CAD -22080000 1.74M Jun/2025
Eli Lilly USD 7.02B 1.61B Jun/2025
Hikma Pharmaceutical USD 282M 45M Dec/2024
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Novartis USD 5.46B 2.06B Jun/2025
Perrigo USD 55.6M 23.8M Jun/2025
Sun Pharmaceuticals INR 33.72B 9.73B Jun/2025
Teva Pharmaceutical Industries USD 899M 380M Jun/2025